STRS Ohio’s Akcea Therapeutics Inc AKCA Stock Holding History

STRS Ohio’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,600	Closed	-$83K	–	2365
2020 Q3	$83K	Buy	+4,600	New	+$65.3K	﹤0.01%	1878
2019 Q1	–	Sell	-14,700	Closed	-$443K	–	2133
2018 Q4	$443K	Hold	14,700	–	–	﹤0.01%	1321
2018 Q3	$514K	Hold	14,700	–	–	﹤0.01%	1369
2018 Q2	$348K	Buy	14,700 +10,400	+242%	+$248K	﹤0.01%	1553
2018 Q1	$110K	Hold	4,300	–	–	﹤0.01%	1584
2017 Q4	$74K	Hold	4,300	–	–	﹤0.01%	1684
2017 Q3	$118K	Buy	+4,300	New	+$79.6K	﹤0.01%	1615

STRS Ohio's AKCA Position: Q4 2020 in Review

STRS Ohio sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 4,600 shares — an estimated $83K sold.

STRS Ohio first reported a position in AKCA in Q3 2017 and held it in 7 quarters. The position peaked at $514K in Q3 2018. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

STRS Ohio reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
STRS Ohio sold 4,600 Akcea Therapeutics Inc shares in Q4 2020, an estimated $83K.
STRS Ohio first reported a position in Akcea Therapeutics Inc in Q3 2017 and held it in 7 quarters.
STRS Ohio's Akcea Therapeutics Inc position peaked at $514K in Q3 2018.
0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on STRS Ohio's 13F filing for Q4 2020, filed 25 Jan 2021.